TY  - GEN
AU  - Ailawadhi,Sikander
AU  - Sexton,Rachael
AU  - Lentzsch,Suzanne
AU  - Abidi,Muneer H
AU  - Voorhees,Peter M
AU  - Cohen,Adam D
AU  - Rohren,Eric M
AU  - Heitner,Stephen
AU  - Kelly,Kevin
AU  - Mackler,Niklas J
AU  - Baer,David M
AU  - Hoering,Antje
AU  - Durie,Brian
AU  - Orlowski,Robert Z
TI  - Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
SN  - 1557-3265
PY  - 2021///1101
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Cross-Over Studies
KW  - Dexamethasone
KW  - Drug Administration Schedule
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Neoplasm Recurrence, Local
KW  - Oligopeptides
KW  - Progression-Free Survival
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-19-1997
ER  -